The Plasma Cell Disorders Working Committee provides scientific oversight for studies related to hematopoietic cell transplant and cellular therapy in multiple myeloma, light chain amyloidosis, and other plasma cell disorders.
Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.
The TCT® Trademark belongs to the Cardiovascular Research Foundation. ASTCT, CIBMTR, MCW, NMDP, the 2019, 2020, and 2021 TCT Conferences and materials are NOT affiliated with or sponsored by Cardiovascular Research Foundation.